Beth Seidenberg and Sean Harper, Westlake Village
December 15, 2020 07:37 AM ESTUpdated April 13, 11:35 AM
Financing

Sean Harp­er and Beth Sei­den­berg add $500M to their new VC, bet­ting on the LA biotech ecosys­tem

Jason Mast

Editor

When Ar­se­nal Bio launched last year, the head­line name was Nap­ster bil­lion­aire Sean Park­er, who, af­ter fund­ing an im­munother­a­py in­sti­tute, de­cid­ed to back a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times